AllVascular


IsoVasc Medical Group specializes in innovative vascular access systems, including the AVAS® implant, designed for targeted chemotherapy delivery and vascular isolation procedures. Their mission is to improve cancer treatment through advanced vascular technology, providing clinicians with tools for precise and repeatable arterial access to treat secondary cancers, particularly in the liver.

Industries

manufacturing
marketing-2795
medical-device

Nr. of Employees

small (1-50)

AllVascular

Greenwich, New South Wales, Australia, Oceania


Products

Implantable arterial access system for repeatable vascular isolation

A surgically implanted arterial access system that provides repeatable and non-percutaneous arterial access for simultaneous multi-catheter procedures, enabling vascular isolation and targeted intra-arterial delivery of therapeutic agents.


Services

Clinical trial support for device-enabled locoregional chemotherapy

Design and execution of clinical feasibility studies for implantable vascular access systems, including physiological monitoring, bioanalytical sampling for drug distribution, and imaging-based outcome measures.

Expertise Areas

  • Locoregional chemotherapy delivery
  • Vascular access device design
  • Clinical trial execution for device-enabled therapies
  • Pharmacokinetic and imaging assessment for regional therapies
  • Show More (2)

Key Technologies

  • Implantable arterial access devices
  • ePTFE vascular graft materials
  • Dual-cuff infection/tissue anchorage design
  • Multi-lumen/multi-catheter sheath systems
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.